Table 1 Demographics characteristics of case and control

From: Surfactant therapy for COVID-19 related ARDS: a retrospective case–control pilot study

  Surfactant
(n = 7, 0.33%)
Control
(n = 14, 0.66%)
P value
Age, mean (SD) 66.14 (4.33) 60.85 (10.79) 0.232
Gender male, n (%) 6 (85.7%) 11(78.6%) 0.873
BMI, mean (SD) 28.60 (4.54) 28.71 (4.49) 0.958
SAPSII, mean (SD) 49.14 (12.30) 43.92 (15.42) 0.447
Cardiopathy, n (%) 5 (71.4%) 4 (28.5%) 0.124
Diabetes, n (%) 1 (14.3%) 2 (14.3%) 0.247
Immunodepression, n (%) 0 (0%) 2 (14.3%) 0.530
Obesity, n (%) 2 (28.6%) 3 (21.4%) 0.998
Pneumopathy, n (%) 1 (14.3%) 0 (0%) 0.335
  1. BMI body mass index (weight in kilograms divided by the square of the height in meters)